Antiviral therapy of COVID-19
نویسندگان
چکیده
منابع مشابه
COVID-19: combining antiviral and anti-inflammatory treatments
The high affinity of baricitinib for the numb-associated kinase (NAK) family, its anti-inflammatory properties, with its advantageous pharmacokinetic properties, appear to make it a special case among the approved drugs. In addition, the potential for combination therapy with baracitinib is high, because of its low plasma protein binding and minimal interaction with CYP enzymes and drug transp...
متن کاملSignificance of exosomes in COVID-19 pathogenesis and therapy
Exosomes are lipid bilayer-enclosed nano-sized vesicles, which carry various biomolecules including proteins, lipids, and microRNAs. SARS-CoV-2-loaded exosomes can be entered into the susceptible host cells, and transported viral components which are associated with viral particles intercellular transmission and spread of infection. Over-stimulation of the immune system followed by excessive pr...
متن کاملPhotodynamic therapy: A new treatment against Covid-19
In 2019, a new coronavirus (COVID-19) was discovered in Wuhan, China, which soon spread all over the world. The main hallmark of the disease includes fever, diarrhea, vomiting, and dry cough with dyspnea in half of the patients and acute respiratory distress syndrome (ARDS). Currently, no definitive treatment or prevention therapy exists for COVID-19 but scientists and researchers all over the ...
متن کاملPlasmapheresis with corticosteroids and antiviral: a life-saving treatment for severe cases of Covid 19 (A case report)
Background: COVID-19 pandemic is a global concern. In this study we suggest using a novel three-dimensional treatment mainly based upon immune system modulation to revolve the virus chaos, regarding to the cytokine storm introduced as the main character of COVID-19 infection scenario. Case Presentation: A young man infected by 2019-nCoVwho suffered from respiratory arrest and loss of conscious...
متن کاملTreatment of COVID-19 patients using plasma therapy: Letter to Editor
The symptoms of COVID-19, caused by the newly known type of coronavirus, vary widely from asymptomatic, mild to severe respiratory infection leading to hospitalization or death of patients. To date, no specific drug has been reported for the treatment of patients affected by this virus. One of the approaches adopted for the treatment of this disease is the use of plasma therapy, which contains ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scripta Medica
سال: 2020
ISSN: 2490-3329,2303-7954
DOI: 10.5937/scriptamed51-28336